Drug Approval | April 11, 2023
Zydus receives final approval from the USFDA for Azithromycin Tablets
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
Subscribe To Our Newsletter & Stay Updated
